Morgan Stanley Call 70 NDA 20.12..../ DE000MG2RV17 /
24/06/2024 11:16:43 | Var.+0.04 | Denaro12:37:32 | Lettera12:37:32 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
5.58EUR | +0.72% | 5.76 Quantità in denaro: 5,000 |
6.06 Quantità in lettera: 5,000 |
AURUBIS AG | 70.00 EUR | 20/12/2024 | Call |
GlobeNewswire
12:50
ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences
GlobeNewswire
12:45
BioNTech and DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate BNT...
GlobeNewswire
12:30
G1 Therapeutics Provides Update on Phase 3 PRESERVE 2 Trial in Patients Receiving Trilaciclib Prior ...
GlobeNewswire
12:30
Hut 8 Announces $150 Million Strategic Investment from Coatue to Partner in Building Next Generation...
GlobeNewswire
12:30
embecta-sponsored Abstracts Presented at American Diabetes Association’s 84th Scientific Sessions Hi...
GlobeNewswire
12:25
Inspiring the Next Generation: Parsons Celebrates Expanded Partnership with Technovation
GlobeNewswire
12:00
Lotus Technology Recognized as a Global Leader for Demonstrating Excellence Across ESG Commitment
GlobeNewswire
12:00
Sonoco to Acquire Eviosys, Creating The World’s Leading Metal Food Can and Aerosol Packaging Platfor...
GlobeNewswire
12:00
Entrada Therapeutics Reports Positive Preliminary Data in Healthy Volunteers from Phase 1 ENTR-601-4...
GlobeNewswire
12:00
Comstock Metals Receives County Operating and Storage Permit for Recycling Expansion
GlobeNewswire
12:00
Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates